Complexities and challenges in managed care

Journal of Managed Care Pharmacy

Volumn 14, Issue 5 SUPPL. A, 2008, Pages

  Cardarelli, William J ^a  

^a HARVARD VANGUARD MEDICAL ASSOCIATES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; DARUNAVIR; ETRAVIRINE; LAMIVUDINE; MARAVIROC; NELFINAVIR; RALTEGRAVIR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ARTICLE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG FORMULARY; DRUG LEGISLATION; DRUG UTILIZATION; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH CARE QUALITY; HEALTH PROGRAM; HEPATITIS B; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MANAGED CARE; MEDICAID; MEDICARE; MIXED INFECTION; PHARMACY; PRACTICE GUIDELINE; REIMBURSEMENT;

EID: 48449086983     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. U.S. Department of Health and Human Services Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents (DHHS Guidelines) - January 29, 2008. Available at: www.aidsinfo.nih.gov/ guidelines/GuidelineDetail.aspx?Menultem=Guidelines&Search= Off&GuidelineID=7&ClassID=1. Accessed April 1, 2008.
2. HIV Guidelines and Educational Materials Developed by Other Organizations. Available at: www.hivma.org/Content.aspx?id=1918. Accessed April 1, 2008.
3. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45(2):507-39. Erratum in: Hepatology. 2007;45(6):1347.
4. Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok AS. Management of hepatitis B: summary of a clinical research workshop. Hepatology. 2007;45(4):1056-75.
5. Keeffe EB, Dieterich, DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States, an update. Clin Gastroenterol Hepatol. 2006;4(8):936-62.
6. Keeffe EB, Zeuzem S, Koff RS, et al. Report of an international workshop: roadmap for management of patients receiving oral therapy for chronic hepatitis B. Clin Gastroenterol Hepatol. 2007;5(8):890-97.
7. Alberti A, Clumeck N, Collins S, et al. Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. J Hepatol. 2005;42(5):615-24. Erratum in: J Hepatol. 2005;43(6):1098.
8. Benhamou Y. Treatment algorithm for chronic hepatitis B in HIV-infected patients. J Hepatol. 2006;44(1 suppl):S90-S94.
9. Keehan S, Sisko A, Truffer C, et al. Health spending projections through 2017: the baby-boom generation is coming to Medicare. Health Aff (Millwood). 2008;27(2):w145-w155.
10. Express Scripts. 2006 Drug Trend Report.
11. Medco. Drug Trend Report 2007.
12. Zabinski R. Evidence-based health benefits management: strategies to optimize antiretroviral medication adherence and outcomes in HIV/AIDS. J Manag Care Pharm. 2006;12(7 suppl B):S12-S16. Available at: www.amcp.org/data/jmcp/SeptSupplB.pdf